Search Results

For in vitro diagnostic use only. The Drew Scientific Glycated Hemoglobin Five Level Linearity Kit is intended to verify the linearity of HbA1c assays across the patient reportable range (4 to 18%, NGSP aligned) using protocols established in individual laboratories.

Not Found

This document does not contain the information required to describe the acceptance criteria, device performance, or details of a study proving the device meets acceptance criteria.

The provided text is a 510(k) clearance letter from the FDA for a device called "Drew Scientific, Glycated Hemoglobin Five Level Linearity Kit." This letter grants marketing authorization based on a finding of "substantial equivalence" to a predicate device. It is not a study report or a detailed technical submission.

The letter explicitly states:

• "We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent..."
• "FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies."

Therefore, the document does not provide any of the requested information regarding:

1. A table of acceptance criteria and reported device performance.
2. Sample size used for the test set or data provenance.
3. Number and qualifications of experts for ground truth.
4. Adjudication method.
5. MRMC comparative effectiveness study results or effect size.
6. Standalone algorithm performance.
7. Type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

This document serves as an FDA clearance notice, not a performance study.

Ask a specific question about this device